Clinical trial
Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug…
NCT00373204 · Pharmacyclics LLC., Industry · Terminated
Key facts
| NCT number | NCT00373204 |
|---|---|
| Title | Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere) |
| Official title | Phase II Trial of Motexafin Gadolinium and Docetaxel for Second Line Treatment of Patients With Advanced Non-small Cell Lung Cancer |
| Lead sponsor | Pharmacyclics LLC., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | Motexafin Gadolinium |
| Enrollment | 50 |
| Start date | May 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Sep 7, 2006 |
| Last update posted | Jul 24, 2014 |
| Countries | Canada, Russia, Serbia, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: